Selling the Stem Cell Promise
The potential of stem cells’ curative powers has spawned the creation of private tissue banks. But marketing is outpacing the medicine.
Article
New Company is Only in U.S. That Stores Frozen Immune Cells Giving Clients Options for Future Medical Treatments
BioBancUSA(TM) launches the nation’s first revolutionary immune cell preservation center dedicated to providing ‘bioinsurance’ against disease. Several of the world’s foremost physicians have developed the advanced technology to collect and store an individual’s immune cells as insurance against future disease.
Article
Hospital Offers Option for Storing Stem Cells from Cord, Placenta
Officials at St. Barnabas Medical Center said yesterday they have established the program with LifebankUSA of Cedar Knolls, a division of Celgene, a Summit biotechnology company.
Article
Cord Blood America Completes CorCell, Inc. Acquisition
With this announcement, Cord Blood America completes the acquisition of the CorCell Sample, fully acquiring approximately 12,000 customers.
Article
Stemagen and UPenn Partner to Advance the Therapeutic Use of New and Unique Type of Human Embryonic Stem Cell
Stemagen Corporation announced today it has acquired the exclusive rights to a patent for a groundbreaking technique that allows the development of embryonic stem cells appearing to have a markedly enhanced potential for therapeutic use – uniparental embryonic stem cells.
Article
Biotech Firm Gel-Del is Just Beginning to Jell Well
A St. Paul company is a year away from bringing its first product to market, but a California firm still signed a $15 million licensing deal to distribute it.
Article
Mesoblast’s Road to United States Product Registration
Australia’s adult stem cell company, Mesoblast Limited, has provided investors with a timetable and update of proposed clinical programs leading to product registration in the United States, the world’s largest health care market.
Article
EU Supports Cell Therapy Project, Fosters Dialogue with Patient Groups
The EU has given the green light to a new project that focuses on the most common and debilitating form of muscular dystrophy, known as Duchenne Muscular Dystrophy (DMD). The project has identified a gap in the current body of knowledge concerning stem cell therapies for DMD, and aims to pool existing studies into a single knowledge base that can be used as a synthesised resource in a final preparatory stage leading to clinical studies.
Article
University of Massachusetts Considers Stem Cell Research Center
The University of Massachusetts could position itself as a contender in the stem cell research arena by developing a new system-wide institute to advance life sciences through human and animal research, according to a report to the university’s board of trustees.
Article
Stem Cell Innovations Names Ian Lyons, Ph.D., U.S. Chief Scientific Officer
Stem Cell Innovations, Inc. has announced Ian Lyons, Ph.D., has been appointed Chief Scientific Officer, U.S. Dr. Lyons joins Helmuth van Es, Ph.D., Chief Scientific Officer, Europe, as co-leader of Stem Cell Innovation’s scientific programs. Dr. Lyons helped develop and characterize several of the human embryonic stem cell lines that are on the list approved for federally funded research in the U.S.
Article
t2cure Appoints Dr. Manfred Ruediger as CEO
t2cure, a biopharmaceutical company engaged in the field of stem cell-based regenerative medicine, has announced that it has appointed Dr. Manfred Ruediger as CEO.
Article